Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.

Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor. Abstract Text:

Randi Sørby,Arild Espenes,Thor Landsverk,Gunilla Westermark,

Studies of amyloid enhancing factor (AEF)-induced amyloidosis are commonly performed in mice. In mink, earlier studies of amyloid A (AA) amyloidosis showed that the predeposition phase was highly variable. Thus, the aim of the study was to establish an AEF-induced AA amyloidosis model in mink to facilitate studies of early amyloid deposition in a species with prominent ellipsoids, anatomical structures lacking in mice but present in most other mammals. AEF was extracted from mink spleens containing AA. Mink received one intravenous injection of AEF and repeated subcutaneous injections of lipopolysaccharide (LPS) as an inflammatory stimulus. On day 4, small amounts of amyloid were detected in the marginal zone in the spleen. On day 7, considerable amyloid deposition was detected in the ellipsoids and marginal zones in the spleen and in the space of Disse in the liver. By immunohistochemistry, the deposits were identified as AA amyloid. Immunolabeling was also detected in lymphoid follicles and the red pulp of some animals. Control animals receiving only AEF were negative. Control animals receiving only LPS were negative except for one of three animals which had small amounts of amyloid in the spleen. The mink AEF model is a suitable tool to study the development of AA amyloidosis in a species with a spleen containing both well-developed ellipsoids and marginal zone.

Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor. Publishing Authors By Initials

R Sørby,A Espenes,T Landsverk,G Westermark,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Amyloid : the international journal of experimenta

VOLUME: 15

Page Numbers: 20-8

Journal Abbreviation: Amyloid

ISSN: 1350-6129

DAY: 12

MONTH: Mar

YEAR: 2008

Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9433802

Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.

AFFILIATION: Norwegian School of Veterinary Science, Oslo, Norway.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Amyloid

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor Related Publications

• Amyloid contained in the knee joint meniscus is formed from apolipoprotein A-I.
• Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis.
• Amyloid of human islets of Langerhans. II. Electron microscopic analysis of isolated amyloid.
• Amyloidogenic potential of foie gras.
• Amyloidosis in ageing obese-hyperglycemic mice and their lean litter-mates. A morphological study.
• An established human cell line derived from a malignant mediastinal teratoma.
• Density dependent cell cycle inhibition--a universal growth control among normal animal cells.
• Expression of the c-myc proto-oncogene in growth stimulated porcine thyroid follicle cells.
• Germ Line Origin and Somatic Mutations Determine the Target Tissues in Systemic AL-Amyloidosis.
• Growth factor receptors in thyroid follicle cells.
• Growth stimulation of aged cells in culture.
• In vitro differentiation and specialization of cell surfaces in human glia-like cells.
• Lactadherin binds to elastin--a starting point for medin amyloid formation?
• Occurrence of amyloid deposits in the skin in secondary systemic amyloidosis.
• PDGF-like growth factors in autocrine stimulation of growth.
• Plasma membrane motility of cultured human glia cells in phase II and III.
• Psychopathology and personality traits in patients with treated Wilson disease grouped according to gene mutations.
• Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.
• Real-time monitoring of apoptosis by caspase-3-like protease induced FRET reduction triggered by amyloid aggregation.
• Role of aggregated medin in the pathogenesis of thoracic aortic aneurysm and dissection.
• Skin involvement in secondary amyloidosis.
• Structural and functional properties of thyroid follicle cells in culture.
• Studies on human foetal endocrine pancreas in vitro.
• Substance P and enteroglucagon-like immunoreactivity in argentaffin and argyrophil midgut carcinoid tumours.
• The fine structure of growing human glia and glioma cells. Whole cell preparations.
• The pancreatic islets in systemic amyloidosis. The occurrence of two different types of amyloid.
• The spreading of human normal glial and malignant glioma cells in culture. Studies on standard culture conditions.
• Transthyretin and amyloid in the islets of langerhans in type-2 diabetes.
• Ultrastructural features of cultured human glia and glioma cells.
• Unreliability of immunohistochemistry for typing amyloid deposits.